Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Troy Kemp"'
Autor:
Lili Wang, Paul N. Patrone, Anthony J. Kearsley, Jerilyn R. Izac, Adolfas K. Gaigalas, John C. Prostko, Hyung Joon Kwon, Weichun Tang, Martina Kosikova, Hang Xie, Linhua Tian, Elzafir B. Elsheikh, Edward J. Kwee, Troy Kemp, Simon Jochum, Natalie Thornburg, L. Clifford McDonald, Adi V. Gundlapalli, Sheng Lin-Gibson
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15705 (2023)
COVID-19 has highlighted challenges in the measurement quality and comparability of serological binding and neutralization assays. Due to many different assay formats and reagents, these measurements are known to be highly variable with large uncerta
Externí odkaz:
https://doaj.org/article/964a2ccf770f43cdb30f18f0fd8a3ed6
Autor:
Deborah Watson-Jones, ProfPhD, John Changalucha, MSc, Hilary Whitworth, PhD, Ligia Pinto, PhD, Paul Mutani, MD, Jackton Indangasi, MSc, Troy Kemp, PhD, Ramadhan Hashim, BSc, Beatrice Kamala, Dip, Rebecca Wiggins, PhD, Twaib Songoro, BA, Nicholas Connor, MSc, Gladys Mbwanji, MSc, Miquel A Pavon, PhD, Brett Lowe, MSc, Devis Mmbando, BSc, Saidi Kapiga, ProfPhD, Philippe Mayaud, ProfMD, Silvia de SanJosé, MD, Joakim Dillner, ProfPhD, Richard J Hayes, ProfDSc, Charles J Lacey, ProfMD, Kathy Baisley, MSc
Publikováno v:
The Lancet Global Health, Vol 10, Iss 10, Pp e1473-e1484 (2022)
Summary: Background: An estimated 15% of girls aged 9–14 years worldwide have been vaccinated against human papillomavirus (HPV) with the recommended two-dose or three-dose schedules. A one-dose HPV vaccine schedule would be simpler and cheaper to
Externí odkaz:
https://doaj.org/article/b52f22f640384d13ab341ba7a8d80f06
Autor:
Ligia A. Pinto, Allan Hildesheim, Leen-Jan van Doorn, Wim Quint, Gloriana Shelton, Troy Kemp, Rolando Herrero, Ana C. Rodriguez, Mark Schiffman, Sholom Wacholder, Douglas R. Lowy, Paula Gonzalez, John T. Schiller, Aimee Kreimer, Yuanji Pan, Carolina Porras, Mahboobeh Safaeian
The Costa Rica HPV16/18 Vaccine Trial (CVT) showed that four-year vaccine efficacy against 12-month HPV16/18 persistent infection was similarly high among women who received one, two, or the recommended three doses of the bivalent HPV16/18 L1 virus-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af7092ee4d86245d1f513994d6d6976
https://doi.org/10.1158/1940-6207.c.6544847
https://doi.org/10.1158/1940-6207.c.6544847
Autor:
Ligia A. Pinto, Allan Hildesheim, Leen-Jan van Doorn, Wim Quint, Gloriana Shelton, Troy Kemp, Rolando Herrero, Ana C. Rodriguez, Mark Schiffman, Sholom Wacholder, Douglas R. Lowy, Paula Gonzalez, John T. Schiller, Aimee Kreimer, Yuanji Pan, Carolina Porras, Mahboobeh Safaeian
Fig. S1A: Individual HPV16 kinetics among the 1 dose group. Fig. S1B: Individual HPV18 kinetics among the 1 dose group. Fig. S1C: Individual HPV16 kinetics among the 2-dose(0/1) group. Fig. S1D: Individual HPV18 kinetics among the 2-dose(0/1) group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077d6739fe2e4b56e5a3696573d5e85b
https://doi.org/10.1158/1940-6207.22525667
https://doi.org/10.1158/1940-6207.22525667
Publikováno v:
Cancer Research. 83:LB054-LB054
The sudden onset of the 2019 SARS-CoV-2 pandemic required agile development of standards and efficient validation of assays to assess prevalence of infection as well as immune responses to infection and vaccination. Leveraging their experience in HPV
Autor:
Ribhi Shawar, Brendan O’Leary, Troy Kemp, James Cherry, S Michele Owen, Pamela Gallagher, Natalie Thornburg, Marina Kondratovich, Subbian Satheshkumar Panayampalli, Amy Schuh, Sandra Lester, Cristina Cassetti, Douglas Lowy, Steve R Gitterman
Publikováno v:
Open Forum Infectious Diseases
Background The emergence of the novel coronavirus, SARS-CoV-2, created a crucial need for accurate tests for diagnosis, assessment of prior infection, and understanding its natural history. Serology assays play an important role in the assessment of
Autor:
Ligia Pinto, not provided Troy Kemp
Luminex Milliplex Cytokine/Chemokine 22-plex MAG manufacturer's protocol.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac3497ed176857176d7b33fb15c329f3
https://doi.org/10.17504/protocols.io.hvdb626
https://doi.org/10.17504/protocols.io.hvdb626
Autor:
Ligia Pinto, not provided Troy Kemp
Luminex Milliplex Cytokine/Chemokine 9-plex MAG manufacturer's protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2270ba6234c1b43b4dd075f19102d7c
https://doi.org/10.17504/protocols.io.hvhb636
https://doi.org/10.17504/protocols.io.hvhb636
Autor:
Ligia Pinto, not provided Troy Kemp
Luminex Milliplex Cardiovascular Disease 3-plex Panel 2 instructions per manufacturer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7347bc3b44255bdda7bbc60a8a25ca
https://doi.org/10.17504/protocols.io.hvcb62w
https://doi.org/10.17504/protocols.io.hvcb62w
Autor:
Troy Kemp, not provided Ligia Pinto
Luminex Mulliplex Cytokine/Chemokine 17-plex MAG manufacturer's protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89ef17e33fd555291f6a6d956d08eddf
https://doi.org/10.17504/protocols.io.hvfb63n
https://doi.org/10.17504/protocols.io.hvfb63n